Induction of plasminogen activator inhibitor type 1 and type 1 collagen expression in rat cardiac microvascular endothelial cells by interleukin-1 and its dependence on oxygen-centered free radicals

Circulation

Volumn 97, Issue 21, 1998, Pages 2175-2182

  Okada, Hitoshi ^a   Woodcock Mitchell, Janet ^a   Mitchell, John ^a   Sakamoto, Tomohiro ^a   Marutsuka, Kousuke ^a   Sobel, Burton E ^a   Fujii, Satoshi ^a  

^a UNIVERSITY OF VERMONT   (United States)

Author keywords

Coronary disease; Endothelium; Interleukins; Plasminogen activators

Indexed keywords

COLLAGEN TYPE 1; INTERLEUKIN 1; OXYGEN RADICAL; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FIBRINOLYSIS; IMMUNOHISTOCHEMISTRY; MICROCIRCULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; RAT; VASCULAR ENDOTHELIUM;

EID: 0032474468     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.97.21.2175     Document Type: Article

References (37)

1. Hamsten A, Eriksson P. Fibrinolysis and atherosclerosis: an update. Fibrinolysis. 1994;8:253-262.
2. Loskutoff DJ. Regulation of PAI-1 gene expression. Fibrinolysis. 1991;5:197-206.
3. Vaddi K, Nicolini FA, Mehta P, Mehta JL. Increased secretion of tumor necrosis factor-α and interferon-γ by mononuclear leukocytes in patients with ischemic heart disease: relevance in Superoxide anion generation. Circulation. 1994;90:694-699.
4. Kukielka GL, Smith CW, Manning AM, Youker KA, Michael LH, Entman ML. Induction of interleukin-6 synthesis in the myocardium: potential role in postreperfusion inflammatory injury. Circulation. 1995;92:1866-1875.
5. Dinarello CA. Biologic basis for interleukin-1 in disease. Blood. 1996;87:2095-2147.
6. Pannekoek H, Veerman H, Lambers H, Diergaarde P, Verweij CL, Zonneveld AJ, Mourik JA. Endothelial plasminogen activator inhibitor (PAI): a new member of the serpin family. EMBO J. 1986;5:2539-2544.
7. Wojta J, Zoellner H, Gallicchio M, Hamilton JA, McGrath K. γ-Interferon counteracts interleukin-1α stimulated expression of urokinase-type plasminogen activator in human endothelial cells in vitro. Biochem Biophys Res Commun. 1992;188:463-469.
8. Zoellner H, Wojta J, Gallicchio M, McGrath K, Hamilton J. Cytokine regulation of the synthesis of plasminogen activator inhibitor-2 by human vascular endothelial cells. Thromb Haemost. 1993;69:135-140.
9. Gallicchio M, Wojta JA, Hamilton JA, McGrath K. Regulation of plasminogen activator inhibitor type 1 in cultured smooth muscle cells by interleukin 1α and tumour necrosis factor-α. Fibrinolysis. 1995;9:145-151.
10. Amento EP, Ehsani N, Palmer H, Libby P. Cytokines and growth factors positively and negatively regulate interstitial collagen gene expression in human vascular smooth muscle cells. Arterioscler Thromb. 1991;11:1223-1230.
11. Nishida M, Carley WW, Gerritsen ME, Ellingsen O, Kelly RA, Smith TW. Isolation and characterization of human and rat cardiac microvascular endothelial cells. Am J Physiol. 1993;264:H639-H652.
12. Shatos MA, Orfeo T, Doherty JM, Penar P, Collen D, Mann KG. α-Thrombin stimulates urokinase production and DNA synthesis in cultured human cerebral microvascular endothelial cells. Arterioscler Thromb Vanc Biol. 1995;15:903-911.
13. Fujii S, Sobel BE. Induction of plasminogen activator inhibitor by products released from platelets. Circulation. 1990;82:1485-1493.
14. Sawa H, Sobel BE, Fujii S. Potentiation by hypercholesterolemia of the induction of aortic intramural synthesis of plasminogen activator inhibitor type 1 by endothelial injury. Circ Res. 1993;73:671-680.
15. Strauss BH, Robinson R, Batchelor WB, Chisholm RJ, Ravi G, Natarajan MK, Logan RA, Mehta SR, Levy DE, Ezrin AM, Keeley FW. In vivo collagen turnover following experimental balloon angioplasty injury and the role of matrix metalloproteinases. Circ Res. 1996;79:541-550.
16. Huang D, Amero SA. Measurement of antigen by enhanced chemiluminescent Western blot. Biotechniques. 1997;22:454-458.
17. Winrow VR, Winyard PC, Morris CJ, Blake DR. Free radicals in inflammation: second messengers and mediators of tissue destruction. Br Med Bull. 1993;49:506-522.
18. Baud L, Fouqueray B, Philippe C, Ardaillou R. Reactive oxygen species as glomerular autacoids. J Am Soc Nephrol. 1992;2:S132-S138.
19. Radeke HH, Meier B, Topley N, Floge J, Habermehl GG, Resch K. Interleukin 1-alpha and tumor necrosis factor-alpha induce oxygen radical production in mesangial cells. Kidney Int. 1990;37:767-775.
20. Freeman BA, Crapo JD. Biology of disease: free radicals and tissue injury. Lab Invest. 1982;47:412-426.
21. Mohazzab KM, Kaminski PM, Wolin MS. NADH oxidoreductase is a major source of Superoxide anion in bovine coronary artery endothelium. Am J Physiol. 1994;266:H2568-H2572.
22. Rajagopalan S, Kura S, Münzel T, Tarpey M, Freeman B, Griendling K, Harrison D. Angiotensin II mediated hypertension in the rat increases vascular Superoxide production via membrane NADH/NADPH oxidase activation: contribution to alterations of vasomotor tone. J Clin Invest. 1996;97:1916-1923.
23. Rosen P, Ballhausen T, Bloch W, Addicks K. Endothelial relaxation is disturbed by oxidative stress in the diabetic rat heart: influence of tocopherol as amioxidam. Diabrtologia. 1995;38:1157-1168.
24. Brilla CG, Matsubara L, Weber KT. Advanced hypertensive heart disease in spontaneously hypertensive rats: lisinopril-mediated regression of myocardial fibrosis. Hypertension. 1996;28:269-275.
25. Bishop JE, Creenbaum R, Gibson DG, Yacoub M, Laurent GJ. Enhanced deposition of predominantly type I collagen in myocardial disease. J Mol Cell Cardiol. 1990;22:1157-1165.
26. Factor S.M. Minase T, Cho S, Dominitz R, Sonnenblick EH. Microvascular spasm in the cardiomyopathic Syrian hamster: a preventable cause of focal myocardial necrosis. Circulation. 1982;66:342-354.
27. Flaherty JT. Myocardial injury mediated by oxygen free radicals. Am J Med. 1991;91:79S-85S.
28. Grech ED, Bellamy CM, Jackson MJ, Muirhead RA, Faragher EB, Ramsdale DR. Free-radical activity after primary coronary angioplasty in acute myocardial infarction. Am Heart J. 1994;127:1443-1449.
29. Grech ED, Dodd NJ, Jackson MJ, Morrison WL, Faragher EB. Ramsdale DR. Evidence for free radical generation after primary percutaneous transluminal coronary angioplasty recanalization in acute myocardial infarction. Am J Cardiol. 1996;77:122-127.
30. Stephens NG, Parsons A, Schofield PM, Kelly F, Cheeseman K, Mitchinson MJ, Brown MJ. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet. 1996;347:781-786.
31. Habib FM, Springall DR, Davies GJ, Oakley CM, Yacoub MH, Polak JM. Tumour necrosis factor and inducible nitric oxide synthase in dilated cardiomyopathy. Lancet. 1996;347:1151-1155.
32. Zhang Y, Deng Y, Wendt T, Liliensiek B, Bierhaus A, Greten J, Chen W, Hach-Wunderle V, Waldherr R, Ziegler R, Männel D, Stern DM, Nawroth PP. Intravenous somatic gene transfer with antisense tissue factor restores blood flow by reducing tumor necrosis factor-induced tissue factor expression and fibrin deposition in mouse meth-A sarcomas. J Clin Invest. 1996;97:2213-2224.
33. Nishida M, Springhom JP, Kelly RA, Smith TW. Cell-cell signaling between adult rat ventricular myocytes and cardiac microvascular endothelial cells in heterotypic primary culture. J Clin Invent. 1993;91:1934-1941.
34. Ungureanu-Longrois D, Balligand JL, Okada I, Simmons WW, Kobzik L, Lowenstein CJ, Kunkel SL, Michel T, Kelly RA, Smith TW. Contractile responsiveness of ventricular myocytes to isoproterenol is regulated by induction of nitric oxide synthase activity in cardiac microvascular endothelial cells in heterotypic primary culture. Circ Res. 1995;77:486-493.
35. Böttiger BW, Motsch J, Böhrer H, Böker T, Aulmann M, Nawroth PP, Martin E. Activation of blood coagulation after cardiac arrest is not balanced adequately by activation of endogenous fibrinolysis. Circulation. 1995;92:2572-2578.
36. Ito H, Maruyama A, Iwakura K, Takiuchi S, Masuyama T, Hori M, Higashino Y, Fujii K, Minamino T. Clinical implications of the 'no reflow' phenomenon: a predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction. Circulation. 1996;93:223-228.
37. Ito H, Okamura A, Iwakura K, Masuyama T, Hori M, Takiuchi S, Negoro S, Nakatsuchi Y, Taniyama Y, Higashino Y, Fujii K, Minamino T. Myocardial perfusion patterns related to Thrombolysis in Myocardial Infarction perfusion grades after coronary angioplasty in patients with acute anterior wall myocardial infarction. Circulation. 1996;93:1993-1999.